Alkeus Pharmaceuticals

Develops oral therapies for treating serious retinal eye diseases.

BiotechnologyPharmaceuticals

Company facts

Founded
2010
Employees
78
Headquarters
United States
Type
Private
Funding
Series B · $150M · 2023